CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
Tài liệu tham khảo
Tumeh, 2014, PD-1 blockade induces responses by inhibiting adaptive immune resistance, Nature, 515, 568, 10.1038/nature13954
McGranahan, 2016, Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade, Science, 351, 1463, 10.1126/science.aaf1490
Webb, 2014, Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer, Clin. Cancer Res., 20, 434, 10.1158/1078-0432.CCR-13-1877
Djenidi, 2015, CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients, J. Immunol., 194, 3475, 10.4049/jimmunol.1402711
Ganesan, 2017, Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer, Nat. Immunol., 18, 940, 10.1038/ni.3775
Nizard, 2017, Induction of resident memory T cells enhances the efficacy of cancer vaccine, Nat. Commun., 8, 15221, 10.1038/ncomms15221
Savas, 2018, Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis, Nat. Med., 24, 986, 10.1038/s41591-018-0078-7
Clarke, 2019, Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer, J. Exp. Med., 216, 2128, 10.1084/jem.20190249
Mackay, 2012, Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation, Proc. Natl. Acad. Sci. USA, 109, 7037, 10.1073/pnas.1202288109
Hofmann, 2011, E-cadherin promotes accumulation of a unique memory CD8 T-cell population in murine salivary glands, Proc. Natl. Acad. Sci. USA, 108, 16741, 10.1073/pnas.1107200108
Ray, 2004, The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection, Immunity, 20, 167, 10.1016/S1074-7613(04)00021-4
McNamara, 2017, Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids, Sci. Immunol., 2, eaaj1996, 10.1126/sciimmunol.aaj1996
Mackay, 2016, Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes, Science, 352, 459, 10.1126/science.aad2035
Hombrink, 2016, Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells, Nat. Immunol., 17, 1467, 10.1038/ni.3589
Milner, 2017, Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours, Nature, 552, 253, 10.1038/nature24993
Le Floc’h, 2007, Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis, J. Exp. Med., 204, 559, 10.1084/jem.20061524
Anikeeva, 2005, Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes, Proc. Natl. Acad. Sci. USA, 102, 6437, 10.1073/pnas.0502467102
Johnston, 2014, The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function, Cancer Cell, 26, 923, 10.1016/j.ccell.2014.10.018
Guo, 2018, Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing, Nat. Med., 24, 978, 10.1038/s41591-018-0045-3
Duhen, 2018, Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors, Nat. Commun., 9, 2724, 10.1038/s41467-018-05072-0
Parkhurst, 2017, Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression, Clin. Cancer Res., 23, 2491, 10.1158/1078-0432.CCR-16-2680
Gros, 2014, PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors, J. Clin. Invest., 124, 2246, 10.1172/JCI73639
Takada, 2011, Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells, J. Immunol., 186, 775, 10.4049/jimmunol.1000094
Skon, 2013, Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells, Nat. Immunol., 14, 1285, 10.1038/ni.2745
Cepek, 1994, Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin, Nature, 372, 190, 10.1038/372190a0
Shiow, 2006, CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs, Nature, 440, 540, 10.1038/nature04606
Simoni, 2018, Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates, Nature, 557, 575, 10.1038/s41586-018-0130-2
Scott, 2019, TOX is a critical regulator of tumour-specific T cell differentiation, Nature, 571, 270, 10.1038/s41586-019-1324-y
Mackay, 2015, Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention, J. Immunol., 194, 2059, 10.4049/jimmunol.1402256
Guan, 2018, ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates, J. Exp. Med., 215, 1153, 10.1084/jem.20171352
Quintana, 2012, Aiolos promotes TH17 differentiation by directly silencing Il2 expression, Nat. Immunol., 13, 770, 10.1038/ni.2363
Li, 2019, Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma, Cell, 176, 775, 10.1016/j.cell.2018.11.043
Willinger, 2006, Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo, J. Immunol., 176, 1439, 10.4049/jimmunol.176.3.1439
Brummelman, 2018, High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors, J. Exp. Med., 215, 2520, 10.1084/jem.20180684
Im, 2016, Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy, Nature, 537, 417, 10.1038/nature19330
Sade-Feldman, 2018, Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma, Cell, 175, 998, 10.1016/j.cell.2018.10.038
Kurtulus, 2019, Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1(-)CD8(+) Tumor-Infiltrating T Cells, Immunity, 50, 181, 10.1016/j.immuni.2018.11.014
Miller, 2019, Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade, Nat. Immunol., 20, 326, 10.1038/s41590-019-0312-6
Siddiqui, 2019, Intratumoral Tcf1(+)PD-1(+)CD8(+) T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy, Immunity, 50, 195, 10.1016/j.immuni.2018.12.021
Yost, 2019, Clonal replacement of tumor-specific T cells following PD-1 blockade, Nat. Med., 25, 1251, 10.1038/s41591-019-0522-3
Mielke, 2019, TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axis, J. Exp. Med., 216, 1682, 10.1084/jem.20181778
Cheuk, 2017, CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin, Immunity, 46, 287, 10.1016/j.immuni.2017.01.009
Ichiyama, 2011, Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin, Immunity, 34, 741, 10.1016/j.immuni.2011.02.021
Tajima, 2011, IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12, Int. Immunol., 23, 751, 10.1093/intimm/dxr086
Piet, 2011, CD8+ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung, J. Clin. Invest., 121, 2254, 10.1172/JCI44675
Woodberry, 2005, Alpha E beta 7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population, J. Immunol., 175, 4355, 10.4049/jimmunol.175.7.4355
Webb, 2010, Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer, Gynecol. Oncol., 118, 228, 10.1016/j.ygyno.2010.05.016
Franciszkiewicz, 2009, Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention, Cancer Res., 69, 6249, 10.1158/0008-5472.CAN-08-3571
Edwards, 2018, CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment, Clin. Cancer Res., 24, 3036, 10.1158/1078-0432.CCR-17-2257
El-Asady, 2005, TGF-beta-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease, J. Exp. Med., 201, 1647, 10.1084/jem.20041044
Wang, 2015, CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder, J. Urol., 194, 556
Franciszkiewicz, 2013, CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions, Cancer Res., 73, 617, 10.1158/0008-5472.CAN-12-2569
Boutet, 2016, TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment, Cancer Res., 76, 1757, 10.1158/0008-5472.CAN-15-1545
Pascutti, 2019, Peripheral and systemic antigens elicit an expandable pool of resident memory CD8(+) T cells in the bone marrow, Eur. J. Immunol., 49, 853, 10.1002/eji.201848003
Patro, 2017, Salmon provides fast and bias-aware quantification of transcript expression, Nat. Methods, 14, 417, 10.1038/nmeth.4197
Pimentel, 2017, Differential analysis of RNA-seq incorporating quantification uncertainty, Nat. Methods, 14, 687, 10.1038/nmeth.4324
Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS, 16, 284, 10.1089/omi.2011.0118
Bolotin, 2015, MiXCR: software for comprehensive adaptive immunity profiling, Nat. Methods, 12, 380, 10.1038/nmeth.3364
Hothorn, 2003, On the Exact Distribution of Maximally Selected Rank Statistics, Comput. Stat. Data Anal., 43, 121, 10.1016/S0167-9473(02)00225-6